Literature DB >> 28216440

Protective effect of HwangRyunHaeDok-Tang water extract against chronic obstructive pulmonary disease induced by cigarette smoke and lipopolysaccharide in a mouse model.

Na-Rae Shin1, Je-Won Ko1, Sung-Hyeuk Park1, Young-Kwon Cho2, Sei-Ryang Oh3, Kyung-Seob Ahn3, Jung-Min Ryu1, Jong-Choon Kim1, Chang-Seob Seo4, In-Sik Shin5.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Hwangryunhaedok-tang is an oriental herbal formula treated to cure inflammation and gastric disorders in China, Japan, and Korea. We explored the protective effects of Hwangryunhaedok-tang water extract (HRWE) against airway pathophysiological changes caused by cigarette smoke (CS) and lipopolysaccharide (LPS) in a mouse.
MATERIALS AND METHODS: We performed quantitative analyses of five marker components, namely geniposide, baicalin, coptisine, plamatine, and berberine, using high-performance liquid chromatography. Animals were received CS exposure (1h per day) for 7 days. LPS was administered intranasally on day 4. Mice were received HRWE at dose of 100 or 200mg/kg for 1h before CS exposure.
RESULTS: Treatment with HRWE significantly suppressed the increased inflammatory cell count induced by CS and LPS exposure. In addition, reduction in IL-6, TNF-α and IL-1β in broncho-alveolar lavage fluid (BALF) was observed after HRWE treatment. HRWE not only decreased inflammatory cell infiltration in lung, but also decreased the expression of iNOS, NF-κB and matrix metallopeptidase (MMP)-9 in lung tissues.
CONCLUSION: This study showed that HRWE can attenuate respiratory inflammation caused by CS and LPS exposure. Therefore, HRWE has potential for treating airway inflammatory disease.
Copyright © 2017 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Airway inflammation; Chronic obstructive pulmonary disease; Cigarette smoke; HwangRyunHaeDok-tang; Traditional herbal formula

Mesh:

Substances:

Year:  2017        PMID: 28216440     DOI: 10.1016/j.jep.2017.02.027

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  6 in total

1.  Protective Effect of Jianpiyifei II Granule against Chronic Obstructive Pulmonary Disease via NF-κB Signaling Pathway.

Authors:  Long Fan; Ruifeng Chen; Leng Li; Ziyao Liang; Xuhua Yu; Kai Huang; Shuomiao Yin; Lei Wu; Yuanbin Chen; Yinji Xu; Qi Wang; Lin Lin
Journal:  Evid Based Complement Alternat Med       Date:  2018-08-05       Impact factor: 2.629

2.  Triterpene Acids of Loquat Leaf Improve Inflammation in Cigarette Smoking Induced COPD by Regulating AMPK/Nrf2 and NFκB Pathways.

Authors:  Tunyu Jian; Xiaoqin Ding; Jiawei Li; Yuexian Wu; Bingru Ren; Jing Li; Han Lv; Jian Chen; Weilin Li
Journal:  Nutrients       Date:  2020-02-28       Impact factor: 5.717

3.  Yijin-Tang Attenuates Cigarette Smoke and Lipopolysaccharide-Induced Chronic Obstructive Pulmonary Disease in Mice.

Authors:  Jinhyung Rho; Chang-Seob Seo; Eun-Ju Hong; Eun Bok Baek; Eunhye Jung; Suyoung Park; Mee-Young Lee; Hyo-Jung Kwun
Journal:  Evid Based Complement Alternat Med       Date:  2022-01-05       Impact factor: 2.629

4.  Xuanbai Chengqi Decoction Ameliorates Pulmonary Inflammation via Reshaping Gut Microbiota and Rectifying Th17/Treg Imbalance in a Murine Model of Chronic Obstructive Pulmonary Disease.

Authors:  Yongan Wang; Na Li; Qiuyi Li; Zirui Liu; Yalan Li; Jingwei Kong; Ruijuan Dong; Dongyu Ge; Jie Li; Guiying Peng
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-12-07

5.  Baicalin alleviates chronic obstructive pulmonary disease through regulation of HSP72-mediated JNK pathway.

Authors:  Dexun Hao; Yanshuang Li; Jiang Shi; Junguang Jiang
Journal:  Mol Med       Date:  2021-05-30       Impact factor: 6.354

6.  Baicalin Magnesium Salt Attenuates Lipopolysaccharide-Induced Acute Lung Injury via Inhibiting of TLR4/NF-κB Signaling Pathway.

Authors:  Lin Zhang; Lukun Yang; Xiaowei Xie; Hongyue Zheng; Hangsheng Zheng; Lizong Zhang; Cuizhe Liu; Ji-Gang Piao; Fanzhu Li
Journal:  J Immunol Res       Date:  2021-06-08       Impact factor: 4.818

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.